Aug 7 |
Janux Therapeutics Reports Second Quarter 2024 Financial Results and Business Highlights
|
Jul 22 |
Janux Therapeutics Announces Updates to Board of Directors
|
Jul 16 |
UnitedHealth Posts Better-Than-Expected Earnings, Joins AngioDynamics, Bank of America And Other Big Stocks Moving Higher On Tuesday
|
Jun 26 |
Janux Therapeutics: Promising T-Cell Engager Platform In Cancer Therapy
|
Jun 14 |
TruBridge, Evans Bancorp, and More Stocks See Action From Activist Investors
|
May 9 |
We're Not Very Worried About Janux Therapeutics' (NASDAQ:JANX) Cash Burn Rate
|
May 8 |
Janux Therapeutics Reports Narrower Q1 Loss, Misses Revenue Estimates
|
May 7 |
Janux Therapeutics GAAP EPS of -$0.30 beats by $0.03
|
May 7 |
Janux Therapeutics Reports First Quarter 2024 Financial Results and Business Highlights
|
May 2 |
Janux Therapeutics gains amid renewed takeover speculation
|